Pulmonary arterial hypertension market to generate sales of approximately $4.75 billion by the end of 2024
The Pulmonary Arterial Hypertension (PAH) therapeutics market will experience modest growth from $3.45 billion in 2014 to $4.75 billion by 2024, representing a Compound Annual Growth Rate (CAGR) of 3.2%.This report on the global pulmonary arterial hypertension (PAH) market offers an insightful and in-depth assessment of the current and future market potential of PAH drugs.
More informationStroke Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016
Global Markets Direct's, 'Stroke - Pipeline Review, H1 2016', provides an overview of the Stroke pipeline landscape. Read more @ http://www.radiantinsights.com/research/stroke-pipeline-review-h1-2016
More information